DK2069353T3 - Polycykliske midler til behandling af infektioner med respiratorisk syncytialvirus - Google Patents
Polycykliske midler til behandling af infektioner med respiratorisk syncytialvirusInfo
- Publication number
- DK2069353T3 DK2069353T3 DK07815246.9T DK07815246T DK2069353T3 DK 2069353 T3 DK2069353 T3 DK 2069353T3 DK 07815246 T DK07815246 T DK 07815246T DK 2069353 T3 DK2069353 T3 DK 2069353T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- respiratory syncytial
- syncytial virus
- virus infections
- polycyclic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84807306P | 2006-09-28 | 2006-09-28 | |
PCT/AU2007/001429 WO2008037011A1 (en) | 2006-09-28 | 2007-09-26 | Polycyclic agents for the treatment of respiratory syncytial virus infections |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2069353T3 true DK2069353T3 (da) | 2012-02-20 |
Family
ID=39229629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07815246.9T DK2069353T3 (da) | 2006-09-28 | 2007-09-26 | Polycykliske midler til behandling af infektioner med respiratorisk syncytialvirus |
Country Status (22)
Country | Link |
---|---|
US (2) | US8598194B2 (da) |
EP (1) | EP2069353B1 (da) |
JP (1) | JP5340943B2 (da) |
KR (1) | KR101488826B1 (da) |
CN (1) | CN101583614B (da) |
AR (1) | AR063038A1 (da) |
AT (1) | ATE532787T1 (da) |
AU (1) | AU2007302611C1 (da) |
BR (1) | BRPI0717536A2 (da) |
CA (1) | CA2664376C (da) |
DK (1) | DK2069353T3 (da) |
ES (1) | ES2376915T3 (da) |
HK (1) | HK1131988A1 (da) |
IL (1) | IL197783A (da) |
MX (1) | MX2009003336A (da) |
NO (1) | NO20091521L (da) |
NZ (1) | NZ575805A (da) |
PL (1) | PL2069353T3 (da) |
PT (1) | PT2069353E (da) |
TW (1) | TWI423972B (da) |
WO (1) | WO2008037011A1 (da) |
ZA (1) | ZA200901983B (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101723949B (zh) * | 2003-12-24 | 2013-10-23 | 生物区科学管理控股有限公司 | 用于治疗呼吸道合胞体病毒感染的多环试剂 |
TWI423972B (zh) | 2006-09-28 | 2014-01-21 | Biota Scient Management | 治療呼吸系融合細胞病毒感染之多環劑 |
TWI508968B (zh) * | 2010-02-08 | 2015-11-21 | Biota Scient Management | 用於治療呼吸道融合性病毒感染的化合物 |
US8796303B2 (en) * | 2010-11-26 | 2014-08-05 | Biota Scientific Management Pty Ltd. | Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections |
JP5890522B2 (ja) * | 2011-08-05 | 2016-03-22 | ビオタ サイエンティフィック マネージメント ピーティーワイ リミテッド | 呼吸器合胞体ウイルス感染症処置用化合物 |
US9497965B2 (en) * | 2011-11-04 | 2016-11-22 | Syngenta Participations Ag | Pesticidal compounds |
US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL137586C (da) * | 1963-04-11 | |||
US3507863A (en) * | 1963-12-18 | 1970-04-21 | Sandoz Ag | Isoindolones and method for preparing same |
NL126596C (da) * | 1964-02-11 | |||
NL129866C (da) | 1965-09-21 | |||
CH480350A (de) * | 1965-09-21 | 1969-10-31 | Geigy Ag J R | Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen |
US3379733A (en) * | 1965-12-07 | 1968-04-23 | Sandoz Ag | N-(omega-aminoalkyl)isoindoles and method for preparing same |
CH481123A (de) | 1966-09-21 | 1969-11-15 | Geigy Ag J R | Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen |
FR1580180A (da) | 1967-03-14 | 1969-09-05 | ||
CH482697A (de) | 1967-03-17 | 1969-12-15 | Geigy Ag J R | Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen |
US3885037A (en) * | 1968-09-05 | 1975-05-20 | American Home Prod | Method of producing anorexia using imidazolinyl phenyl carbonyl compounds, their acid addition salts and related compounds |
US3935218A (en) * | 1968-09-05 | 1976-01-27 | American Home Products Corporation | Imidazolinyl phenyl carbonyl compounds acid addition salts and related compounds |
US3657221A (en) * | 1969-02-19 | 1972-04-18 | American Home Prod | Process for preparing 9b-substituted-1 - sulfonyl - 1 2 3 9b - tetrahydro-5h-imidazo(2 1-a)isoindol-5-ones |
US3770766A (en) * | 1970-03-10 | 1973-11-06 | American Home Prod | 2-(2-amino-2,2-dialkylamino-3-hydroxy-3-phenyl-1h-benz(f)isoindole-1-ones |
US3624101A (en) * | 1970-03-10 | 1971-11-30 | American Home Prod | 2,3-DIHYDRO-5-ARYL-5H-BENZ{8 f{9 IMIDAZO{8 2,1-a{9 ISOINDOL-5-OLS |
GB1322339A (en) | 1970-03-10 | 1973-07-04 | American Home Prod | Imidazoline derivatives |
US3966955A (en) * | 1974-08-07 | 1976-06-29 | American Home Products Corporation | Anti-ulcer therapy |
US4056536A (en) * | 1976-06-29 | 1977-11-01 | Merck & Co., Inc. | Pyrrolo[2,1-b][3]benzazepines |
US4701208A (en) * | 1983-08-02 | 1987-10-20 | American Cyanamid Company | Dihydroimidazopyrrolopyridine, quinoline, thieno- and furo[2,3-b]pyridine, dihydrothieno- and furo[2,3-b]-pyridine, thieno- and furo[3,2-b]pyridine and dihydrothieno- and furo[3,2-b]pyridine herbicides and method for preparation thereof |
DE3520390A1 (de) * | 1984-07-07 | 1986-02-06 | Bayer Ag, 5090 Leverkusen | Imidazo-pyrrolo-pyridin-derivate |
EP0183993A3 (de) * | 1984-11-16 | 1987-12-09 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | 2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel |
EP0195745B1 (de) * | 1985-03-12 | 1990-09-12 | Ciba-Geigy Ag | Heterocyclisch kondensierte Pyridin-Verbindungen als Herbizide |
DE3534948A1 (de) * | 1985-10-01 | 1987-04-09 | Bayer Ag | Fungizide und wachstumsregulatorische mittel |
US4717414A (en) * | 1986-08-08 | 1988-01-05 | Ppg Industries, Inc. | Herbicidally active imidazopyrrolo-pyridine (or benzene) derivatives |
DE3634952A1 (de) * | 1986-10-14 | 1988-04-21 | Bayer Ag | Imidazo-pyrrolo-pyridin-derivate |
EP0475908A1 (de) * | 1990-09-14 | 1992-03-18 | Ciba-Geigy Ag | Chromogene Lactamverbindungen und ihre Herstellung und Verwendung |
DE4103177A1 (de) | 1991-02-02 | 1992-08-06 | Boehringer Mannheim Gmbh | Thiazolo-(2,3-a)isoindol-derivate und diese enthaltende arzneimittel |
WO1992015310A1 (de) | 1991-02-28 | 1992-09-17 | Boehringer Mannheim Gmbh | Verwendung von tricyclischen isoindolinonen als antivirale arzneimittel, sowie neue optisch aktive isoindolinone |
DE4108395A1 (de) | 1991-03-15 | 1993-01-28 | Boehringer Mannheim Gmbh | Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten |
DE4129779A1 (de) * | 1991-09-07 | 1993-03-11 | Boehringer Mannheim Gmbh | Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel |
JPH0780886B2 (ja) * | 1992-05-15 | 1995-08-30 | ナショナル・サイエンス・カウンシル | 三環結合ヒドロキシグアニジン、その製造法及びそれを含む抗癌組成物 |
AU6729600A (en) | 1999-08-25 | 2001-03-19 | Banyu Pharmaceutical Co., Ltd. | Novel isoindole derivatives |
KR100757223B1 (ko) * | 2000-02-14 | 2007-09-11 | 모빌리티 일렉트로닉스 인크 | 버스 브리지 |
US6489338B2 (en) | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
JP4058663B2 (ja) * | 2000-09-22 | 2008-03-12 | 有機合成薬品工業株式会社 | リボース1−リン酸類及びヌクレオシド化合物の製造方法 |
US6506738B1 (en) | 2000-09-27 | 2003-01-14 | Bristol-Myers Squibb Company | Benzimidazolone antiviral agents |
US20040161846A1 (en) | 2000-11-22 | 2004-08-19 | Mason Anthony John | Method of expression and agents identified thereby |
WO2002066479A1 (fr) | 2001-02-23 | 2002-08-29 | Banyu Pharmaceutical Co.,Ltd. | Derives de l'isoindole |
AUPR878401A0 (en) | 2001-11-09 | 2001-12-06 | Biota Holdings Ltd | Methods for identifying or screening anti-viral agents |
CN101723949B (zh) * | 2003-12-24 | 2013-10-23 | 生物区科学管理控股有限公司 | 用于治疗呼吸道合胞体病毒感染的多环试剂 |
PL3045206T3 (pl) | 2005-04-28 | 2018-08-31 | Viiv Healthcare Company | Wielopierścieniowe pochodne karbamoilopirydonu wykazujące aktywność inhibitorową wobec integrazy HIV |
TWI423972B (zh) | 2006-09-28 | 2014-01-21 | Biota Scient Management | 治療呼吸系融合細胞病毒感染之多環劑 |
-
2007
- 2007-09-20 TW TW096135090A patent/TWI423972B/zh not_active IP Right Cessation
- 2007-09-26 US US12/443,177 patent/US8598194B2/en not_active Expired - Fee Related
- 2007-09-26 NZ NZ575805A patent/NZ575805A/en not_active IP Right Cessation
- 2007-09-26 ES ES07815246T patent/ES2376915T3/es active Active
- 2007-09-26 WO PCT/AU2007/001429 patent/WO2008037011A1/en active Application Filing
- 2007-09-26 BR BRPI0717536-1A patent/BRPI0717536A2/pt not_active IP Right Cessation
- 2007-09-26 PT PT07815246T patent/PT2069353E/pt unknown
- 2007-09-26 AT AT07815246T patent/ATE532787T1/de active
- 2007-09-26 PL PL07815246T patent/PL2069353T3/pl unknown
- 2007-09-26 CN CN200780042767.9A patent/CN101583614B/zh not_active Expired - Fee Related
- 2007-09-26 DK DK07815246.9T patent/DK2069353T3/da active
- 2007-09-26 KR KR1020097008619A patent/KR101488826B1/ko not_active IP Right Cessation
- 2007-09-26 EP EP07815246A patent/EP2069353B1/en active Active
- 2007-09-26 AU AU2007302611A patent/AU2007302611C1/en not_active Ceased
- 2007-09-26 JP JP2009529469A patent/JP5340943B2/ja not_active Expired - Fee Related
- 2007-09-26 CA CA2664376A patent/CA2664376C/en not_active Expired - Fee Related
- 2007-09-26 MX MX2009003336A patent/MX2009003336A/es active IP Right Grant
- 2007-09-27 AR ARP070104296A patent/AR063038A1/es unknown
-
2009
- 2009-03-20 ZA ZA200901983A patent/ZA200901983B/xx unknown
- 2009-03-24 IL IL197783A patent/IL197783A/en not_active IP Right Cessation
- 2009-04-17 NO NO20091521A patent/NO20091521L/no not_active Application Discontinuation
- 2009-12-10 HK HK09111555.5A patent/HK1131988A1/xx not_active IP Right Cessation
-
2013
- 2013-08-30 US US14/015,790 patent/US9675694B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
DK2046767T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
DK1874781T3 (da) | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme | |
DK2019683T4 (da) | Indgivelse af vækstfaktorer til behandling af CNS-lidelser | |
ZA200905990B (en) | Recombinant antibodies for treatment of respriratory syncytial virus infections | |
DK1986633T3 (da) | Behandling af duchennes muskeldystrofi | |
DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
DK1984357T3 (da) | 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme | |
DK2982696T3 (da) | Behandling af akut lymfoblastær leukæmi | |
DK1928438T3 (da) | Anvendelse af ibudilast til behandling af stofafhængighed | |
DK1937633T3 (da) | Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme | |
DK2094676T3 (da) | Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater | |
DK2209784T3 (da) | Forbindelser til behandling af hepatitis C | |
DK2236149T3 (da) | Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme | |
DK1962869T3 (da) | Behandling af luftvejssygdomme | |
DK2010184T3 (da) | Implatanter til behandlingen af dopamin associerede tilstande | |
DK2249866T3 (da) | Anvendelse af et acetylsalicylsyresalt til behandlingen af virusinfektioner | |
DK2164572T3 (da) | Carbamoyl-cyclohexaner til behandling af akut mani | |
DK2216021T3 (da) | Farmaceutisk sammensætning til behandling af overaktiv blære | |
ATE533774T1 (de) | Neuartige nukleosidanaloge zur behandlung von virusinfektionen | |
DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
DK2069353T3 (da) | Polycykliske midler til behandling af infektioner med respiratorisk syncytialvirus | |
DK2022504T3 (da) | Salve til behandling af hæmorider |